85
Views
2
CrossRef citations to date
0
Altmetric
Original

A1 and A3 adenosine receptors alter glutathione status in an organ-specific manner and influence the changes after inhibition of γ-glutamylcysteine ligase

, , , , & , MD , PhD
Pages 304-311 | Received 22 Jul 2008, Published online: 07 Jul 2009
 

Abstract

Adenosine levels are increased in stress and act as anti-oxidant and anti-inflammatory mediators by binding to 4 G-protein-coupled receptors. Using genetically modified mice lacking A1 and A3 adenosine receptors, treated with ip buthionine-[S,R]-sulphoximine injections to inhibit γ-glutamylcysteine ligase, the question was addressed whether these receptors modulate the responses to the stress related to altered glutathione levels. This study determined organ glutathione levels and expression of two sub-units of γ-glutamylcysteine ligase and the cationic xc-transporter and found that deletion of one or both adenosine receptors influenced the responses in an organ-specific manner. The lack of A1 and A3 adenosine receptors is related to decreased basal glutathione content and down-regulation of γ-glutamylcysteine ligase sub-units in several organs. Moreover, responses to buthionine-[S,R]-sulphoximine were different. For example, the lack of A3 adenosine receptors, or their blockade of A3 by MRS 1191, caused a marked increase in gene expression, which was not observed in mice lacking both A1 and A3 receptors. The results indicate that A1 and A3 adenosine receptors play a role in antioxidant responses and their role differs in an organ-specific way.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.